Abu Dhabi Population Genome Initiative

Abu Dhabi's population genome initiative, operated through G42 Healthcare, combines large-scale genomic sequencing with AI-powered analysis to build a precision medicine platform for the UAE. The program leverages G42's compute infrastructure to process genomic data at scale, identifying genetic variants associated with diseases prevalent in Gulf populations including diabetes, cardiovascular disease, and hereditary conditions.

The initiative demonstrates the convergence of Gulf AI and healthcare investments: G42's computing infrastructure, originally built for government and enterprise AI, provides the analytical backbone for genomic research. This dual-use of AI infrastructure — serving both technology and healthcare — maximizes return on the massive data center investments.

The broader strategic vision is positioning the Gulf as a healthcare destination and medical research hub. By building world-class genomic databases for underrepresented populations, Gulf states attract international research partnerships, pharmaceutical company collaborations, and medical tourism — creating high-value economic activity that doesn't depend on oil.